Corporate lawyers have indicated that the U.S. Department of Justice (DOJ) is refocusing its efforts to enforce the False Claims Act (FCA) within the health care industry. Previously, the DOJ’s focus was primarily on hospitals and traditional medical practices, but lawyers now suggest that the focus has shifted towards fraudulent reimbursement claims in telehealth.
The FCA allows the DOJ, as well as private plaintiffs, to sue parties that are suspected of defrauding the government. This may include individuals, companies or other entities, and can thus have profound implications for those working in the health care industry. As Congress seeks to aid in false claims enforcement, this shift in focus could indicate significant changes ahead for the health care and telehealth sectors.
For more information, access the full text of the original article here.